HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gregor Warnecke Selected Research

Surface-Active Agents (Surfactants)

1/2005Iloprost to improve surfactant function in porcine pulmonary grafts stored for twenty-four hours in low-potassium dextran solution.
1/2002Surfactant function in lung transplantation after 24 hours of ischemia: advantage of retrograde flush perfusion for preservation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gregor Warnecke Research Topics

Disease

10Primary Graft Dysfunction
11/2022 - 11/2012
8Heart Failure
01/2024 - 03/2005
8Reperfusion Injury
01/2022 - 06/2002
7Infections
10/2022 - 01/2011
7Bronchiolitis Obliterans Syndrome
09/2015 - 01/2012
6Lung Diseases (Lung Disease)
01/2022 - 12/2015
6Ischemia
01/2022 - 01/2002
6Cystic Fibrosis (Mucoviscidosis)
01/2022 - 03/2009
6Idiopathic Pulmonary Fibrosis
01/2022 - 10/2015
6Pulmonary Hypertension
01/2022 - 02/2015
5Inflammation (Inflammations)
02/2022 - 11/2013
5Arteriosclerosis
01/2019 - 06/2007
4Cardiomyopathies (Cardiomyopathy)
09/2023 - 05/2015
4Congenital Heart Defects (Congenital Heart Defect)
12/2021 - 03/2009
4Respiratory Insufficiency (Respiratory Failure)
11/2020 - 09/2013
4Fibrosis (Cirrhosis)
01/2020 - 12/2015
3Atrial Fibrillation
01/2024 - 10/2021
3Pulmonary Arterial Hypertension
01/2023 - 08/2021
3Chronic Obstructive Pulmonary Disease (COPD)
02/2022 - 01/2020
3Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 10/2019
3Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2021 - 09/2013
3Pneumonia (Pneumonitis)
10/2019 - 01/2015
2Wounds and Injuries (Trauma)
11/2022 - 10/2017
2Coronary Artery Disease (Coronary Atherosclerosis)
11/2022 - 10/2022
2Low Cardiac Output
01/2022 - 04/2020
2Emphysema
01/2022 - 10/2015
2Asthma (Bronchial Asthma)
11/2021 - 01/2018
2Neoplasms (Cancer)
08/2021 - 01/2019
2Endocarditis
01/2021 - 12/2019
2Acute Kidney Injury (Acute Renal Failure)
12/2020 - 01/2018
2Pulmonary Edema
01/2020 - 01/2019
2Stroke (Strokes)
11/2019 - 09/2015
2Pulmonary Embolism
06/2019 - 01/2019
2Disease Progression
09/2017 - 03/2013
2Hemorrhage
07/2017 - 12/2012
2Bronchiolitis Obliterans
01/2017 - 12/2015
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
06/2015 - 11/2013
2Eisenmenger Complex (Eisenmenger's Syndrome)
06/2015 - 03/2009
2Surfactant Dysfunction
09/2005 - 07/2004
1Mediastinitis
12/2023
1Renal Cell Carcinoma (Grawitz Tumor)
11/2023
1Hypothermia
11/2023
1Cardiogenic Shock
09/2023
1Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
03/2023
1Amyloidosis
01/2023
1Wound Infection (Wound Infections)
10/2022
1Atrial Flutter (Flutter, Atrial)
10/2022
1Type 2 Diabetes Mellitus (MODY)
01/2022
1Lung Neoplasms (Lung Cancer)
12/2021
1Heart Diseases (Heart Disease)
11/2021
1Bundle-Branch Block (Fascicular Block)
10/2021

Drug/Important Bio-Agent (IBA)

8CytokinesIBA
02/2022 - 01/2005
6PotassiumIBA
09/2015 - 06/2002
5Prostaglandins DIBA
11/2022 - 06/2014
4Dextrans (Dextran)FDA Link
09/2015 - 01/2005
3Biomarkers (Surrogate Marker)IBA
12/2020 - 12/2015
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2018 - 03/2015
3CelsiorIBA
09/2015 - 06/2002
3SolutionsIBA
09/2015 - 01/2005
3Phenobarbital (Luminal)FDA Link
01/2015 - 06/2007
2LipopolysaccharidesIBA
02/2022 - 11/2013
2Proteins (Proteins, Gene)FDA Link
02/2022 - 01/2017
2Anti-Bacterial Agents (Antibiotics)IBA
05/2020 - 01/2020
2prostaglandin D3IBA
11/2019 - 01/2018
2ChemokinesIBA
01/2018 - 01/2015
2Interleukin-6 (Interleukin 6)IBA
10/2016 - 09/2015
2VaccinesIBA
01/2016 - 01/2013
2Isoantigens (Alloantigen)IBA
01/2015 - 06/2007
2Glycine (Aminoacetic Acid)FDA LinkGeneric
03/2006 - 03/2006
2Surface-Active Agents (Surfactants)IBA
01/2005 - 01/2002
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2024
1Polytetrafluoroethylene (Teflon)FDA Link
12/2023
1Oxygen (Dioxygen)IBA
11/2022
1NitrogenIBA
11/2022
1SmokeIBA
02/2022
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
02/2022
1Interleukin-17 (Interleukin 17)IBA
01/2022
1Interleukin-22 (IL-22)IBA
01/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1Potassium Channels (Potassium Channel)IBA
01/2022
1Antiviral Agents (Antivirals)IBA
11/2021

Therapy/Procedure

32Lung Transplantation
01/2023 - 01/2002
15Therapeutics
01/2024 - 05/2006
15Heart Transplantation (Grafting, Heart)
12/2023 - 03/2005
15Transplantation
01/2023 - 07/2004
10Extracorporeal Membrane Oxygenation
11/2022 - 11/2013
5Organ Transplantation
12/2021 - 01/2018
4Artificial Respiration (Mechanical Ventilation)
11/2020 - 11/2012
4Lasers (Laser)
10/2019 - 12/2015
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
09/2023 - 11/2019
3Heart-Assist Devices
10/2022 - 10/2017
3Heart-Lung Transplantation
01/2022 - 11/2007
3Liver Transplantation
10/2021 - 03/2006
2Cardiopulmonary Bypass (Heart-Lung Bypass)
11/2023 - 01/2022
2Palliative Care (Palliative Therapy)
12/2021 - 12/2021
2Drug Therapy (Chemotherapy)
12/2021 - 01/2021
2Sternotomy
10/2018 - 10/2017
1Electric Countershock (Cardioversion)
01/2024
1Stents
10/2022
1Contraindications
08/2021